P

Inventor

RING AARON MICHAEL

US27 patents
⚠️ This page may combine multiple inventors who share the name “RING AARON MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV LELAND STANFORD JUNIOR

24 patents
US10081680B2Sep 25, 2018

Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies

UNIV LELAND STANFORD JUNIOR42 citations97
US9562087B2Feb 7, 2017

High affinity PD-1 agents and methods of use

UNIV LELAND STANFORD JUNIOR45 citations96
US9546206B2Jan 17, 2017

High affinity PD-1 agents and methods of use

UNIV LELAND STANFORD JUNIOR33 citations96
US9944911B2Apr 17, 2018

High affinity Sirp-alpha reagents and methods of using

UNIV LELAND STANFORD JUNIOR23 citations93
US10406179B2Sep 10, 2019

Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

UNIV LELAND STANFORD JUNIOR16 citations92
US10781256B2Sep 22, 2020

Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies

UNIV LELAND STANFORD JUNIOR14 citations85
US10611842B2Apr 7, 2020

Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPα antibody therapy

UNIV LELAND STANFORD JUNIOR8 citations84
US10316094B2Jun 11, 2019

Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance

UNIV LELAND STANFORD JUNIOR9 citations84
US11208481B2Dec 28, 2021

High affinity SIRP-alpha reagents and methods of using

UNIV LELAND STANFORD JUNIOR7 citations83
US10800830B2Oct 13, 2020

High affinity PD-1 agents and methods of use

UNIV LELAND STANFORD JUNIOR6 citations82
US12195532B2Jan 14, 2025

High affinity SIRP-alpha reagents and methods of using

UNIV LELAND STANFORD JUNIOR1 citations74
US10889649B2Jan 12, 2021

Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance

UNIV LELAND STANFORD JUNIOR2 citations73
US11419897B2Aug 23, 2022

Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

UNIV LELAND STANFORD JUNIOR2 citations71
US10618976B2Apr 14, 2020

SIRP-α agonist antibody

UNIV LELAND STANFORD JUNIOR5 citations69
US11718675B2Aug 8, 2023

Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPalpha antibody therapy

UNIV LELAND STANFORD JUNIOR0 citations62
US11459388B2Oct 4, 2022

Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance

UNIV LELAND STANFORD JUNIOR0 citations62
US12233093B2Feb 25, 2025

Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

UNIV LELAND STANFORD JUNIOR0 citations61
US11814419B2Nov 14, 2023

High affinity PD-1 agents and methods of use

UNIV LELAND STANFORD JUNIOR0 citations61
US11041868B2Jun 22, 2021

Compositions comprising G protein-coupled receptors maintained in a conformationally selective manner by a modulator

UNIV LELAND STANFORD JUNIOR0 citations61
US10829771B2Nov 10, 2020

Compositions and methods for expressing polypeptides on the surface of cells

UNIV LELAND STANFORD JUNIOR1 citations61
US10934331B2Mar 2, 2021

Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells

UNIV LELAND STANFORD JUNIOR0 citations60
US10358472B2Jul 23, 2019

High affinity CD47 analogs

UNIV LELAND STANFORD JUNIOR0 citations51
US9880179B2Jan 30, 2018

Method for selecting agents that bind to transmembrane receptors in a conformationally selective manner

UNIV LELAND STANFORD JUNIOR0 citations51
US10520516B2Dec 31, 2019

Complexes comprising transmembrane receptors and antibodies that bind the receptors in a conformationally selective manner

UNIV LELAND STANFORD JUNIOR0 citations50

AB INITIO BIOTHERAPEUTICS INC

3 patents